The extraordinary general meeting of Alexandria New Medical Center endorsed the entitlement of secondary shares of capital increase to FY14 dividend.
The board had approved the decision of the Egyptian Financial Supervisory Authority (EFSA) that the shares of increasing capital by 2.42 million shares from 2.42 million shares to 4.84 million shares have the same right as original shares in dividend distribution for the fiscal year ending December 31, 2014.
The EGM also approved reducing the stock par value from EGP 10 to EGP 8, with the aim of complying with listing regulations.
The company had posted 9% growth in net profit for the first nine months of FY13 to EGP 7.982 million, compared with EGP 7.323 million net profit in the same period a year earlier.
Financial statements for H1-FY14 showed 23.8% growth in net profit to EGP 5.937 million, compared with EGP 4.796 million in the same period a year earlier.
Q1 net profit had amounted to EGP 2.847 million, with a slight decline by 6.4% from EGP 3.044 million in the same period a year earlier.
The company posted a slight rise in 2013 net profit by 2.6% to EGP 9,869,545, compared with EGP 9,610,991 in the same period a year earlier.